Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.004x

Jilin Aodong Pharmaceutical Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥112.12 Million ≈ $16.41 Million USD) by net assets (CN¥30.82 Billion ≈ $4.51 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jilin Aodong Pharmaceutical Group Co Ltd (1998–2025)

Cash flow conversion efficiency of Jilin Aodong Pharmaceutical Group Co Ltd from 1998 to 2025. This chart illustrates how Jilin Aodong Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Jilin Aodong Pharmaceutical Group Co Ltd stock quote for real-time trading data and today's change.

Jilin Aodong Pharmaceutical Group Co Ltd Cash Flow Conversion Ratio Explained

Jilin Aodong Pharmaceutical Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jilin Aodong Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jilin Aodong Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Also see 000623 company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Digitalbridge Group Inc NYSE:DBRG	0.018x
Agilysys Inc NASDAQ:AGYS	0.023x
Stadler Rail AG SW:SRAIL	0.008x
Fujian Sunner Development Co Ltd SHE:002299	0.143x
Relay Therapeutics Inc NASDAQ:RLAY	-0.080x
First BanCorp F:OLWN	0.072x
ERMENEGILDO ZEG.DL -0001 F:JN0	N/A
Bavarian Nordic CO:BAVA	0.042x

Annual Cash Flow Conversion Efficiency for Jilin Aodong Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Jilin Aodong Pharmaceutical Group Co Ltd from 1998 to 2025. Review 000623 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥30.89 Billion ≈ $4.52 Billion	CN¥272.26 Million ≈ $39.84 Million	0.009x	+333.92%
2024-12-31	CN¥29.28 Billion ≈ $4.28 Billion	CN¥59.48 Million ≈ $8.70 Million	0.002x	-17.92%
2023-12-31	CN¥27.50 Billion ≈ $4.02 Billion	CN¥68.06 Million ≈ $9.96 Million	0.002x	-84.62%
2022-12-31	CN¥26.34 Billion ≈ $3.85 Billion	CN¥423.86 Million ≈ $62.02 Million	0.016x	+24.04%
2021-12-31	CN¥25.04 Billion ≈ $3.66 Billion	CN¥324.85 Million ≈ $47.54 Million	0.013x	-21.81%
2020-12-31	CN¥23.53 Billion ≈ $3.44 Billion	CN¥390.41 Million ≈ $57.13 Million	0.017x	-1.86%
2019-12-31	CN¥22.44 Billion ≈ $3.28 Billion	CN¥379.46 Million ≈ $55.53 Million	0.017x	+3.32%
2018-12-31	CN¥21.24 Billion ≈ $3.11 Billion	CN¥347.64 Million ≈ $50.87 Million	0.016x	+30.88%
2017-12-31	CN¥20.51 Billion ≈ $3.00 Billion	CN¥256.49 Million ≈ $37.53 Million	0.013x	-29.31%
2016-12-31	CN¥18.87 Billion ≈ $2.76 Billion	CN¥333.81 Million ≈ $48.85 Million	0.018x	-19.85%
2015-12-31	CN¥17.58 Billion ≈ $2.57 Billion	CN¥388.03 Million ≈ $56.78 Million	0.022x	-3.28%
2014-12-31	CN¥12.66 Billion ≈ $1.85 Billion	CN¥288.83 Million ≈ $42.26 Million	0.023x	+25.87%
2013-12-31	CN¥11.10 Billion ≈ $1.62 Billion	CN¥201.22 Million ≈ $29.44 Million	0.018x	-35.10%
2012-12-31	CN¥9.75 Billion ≈ $1.43 Billion	CN¥272.40 Million ≈ $39.86 Million	0.028x	+134.54%
2011-12-31	CN¥9.09 Billion ≈ $1.33 Billion	CN¥108.30 Million ≈ $15.85 Million	0.012x	-50.47%
2010-12-31	CN¥7.25 Billion ≈ $1.06 Billion	CN¥174.22 Million ≈ $25.49 Million	0.024x	-25.95%
2009-12-31	CN¥6.56 Billion ≈ $959.99 Million	CN¥213.03 Million ≈ $31.17 Million	0.032x	-28.95%
2008-12-31	CN¥5.14 Billion ≈ $752.55 Million	CN¥235.03 Million ≈ $34.39 Million	0.046x	-41.87%
2007-12-31	CN¥4.89 Billion ≈ $716.08 Million	CN¥384.69 Million ≈ $56.29 Million	0.079x	-2.34%
2006-12-31	CN¥2.34 Billion ≈ $341.74 Million	CN¥187.99 Million ≈ $27.51 Million	0.080x	-0.09%
2005-12-31	CN¥1.69 Billion ≈ $247.45 Million	CN¥136.26 Million ≈ $19.94 Million	0.081x	-39.83%
2004-12-31	CN¥1.63 Billion ≈ $238.80 Million	CN¥218.53 Million ≈ $31.98 Million	0.134x	+22.53%
2003-12-31	CN¥1.35 Billion ≈ $197.69 Million	CN¥147.65 Million ≈ $21.61 Million	0.109x	+3137.16%
2002-12-31	CN¥1.27 Billion ≈ $186.07 Million	CN¥-4.58 Million ≈ $-669.59K	-0.004x	-103.06%
2001-12-31	CN¥1.18 Billion ≈ $172.57 Million	CN¥138.76 Million ≈ $20.31 Million	0.118x	+68.14%
2000-12-31	CN¥1.10 Billion ≈ $161.09 Million	CN¥77.04 Million ≈ $11.27 Million	0.070x	-55.67%
1999-12-31	CN¥697.92 Million ≈ $102.13 Million	CN¥110.18 Million ≈ $16.12 Million	0.158x	+414.44%
1998-12-31	CN¥615.37 Million ≈ $90.05 Million	CN¥-30.90 Million ≈ $-4.52 Million	-0.050x	--

About Jilin Aodong Pharmaceutical Group Co Ltd

SHE:000623 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.95 Billion

CN¥20.14 Billion CNY

Market Cap Rank

#4796 Global

#726 in China

Share Price

CN¥16.84

Change (1 day)

+2.75%

52-Week Range

CN¥16.39 - CN¥21.48

All Time High

CN¥24.39